Phase I/II Clinical Trial of Autologous Activated Platelet-Rich Plasma (aaPRP) in the Treatment of Severe Coronavirus Disease 2019 (COVID-19) Patients

• Главные авторы: Karina Karina (Автор), Iis Rosliana (Автор), Imam Rosadi (Автор), Siti Sobariah (Автор), Louis Martin Christoffel (Автор), Rita Novariani (Автор), Siti Rosidah (Автор), Novy Fatkhurohman (Автор), Yuli Hertati (Автор), Nurlaela Puspitaningrum (Автор), Wismo Reja Subroto (Автор), Irsyah Afini (Автор), Difky Ernanda (Автор)
• Формат: ‌
• Опубликовано: Hindawi Limited, 2021-01-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Background. The outbreak of Coronavirus Disease 2019 (COVID-19) has been increasing rapidly. This disease causes an increase in proinflammatory cytokine production that leads to cytokine storm or cytokine release syndrome (CRS). Autologous activated platelet-rich plasma (aaPRP) contains various type...